Embla Medical hf
EMBLA.CO
| Exchange: | CO |
| Currency | Danish krone |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Medical Devices |
| Description: | Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated. Its Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands for therapeutic and preventative purposes; and injury solutions for people recovering from fractures and ligament injuries. The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S. |
| Address: | Grj Oth Als 1-5, Reykjavik, Iceland |
| Website: | https://www.emblamedical.com |
| Full Time Employees: | 4000 |
| Updated On: | 2024-10-15 |
Highlights
| Market Capitalization: | 12637247488 |
| Market Capitalization Mln: | 12637.24 |
| EBITDA: | 115556000 |
| PE Ratio: | 30.51 |
| Wall Street Target Price: | 36.38 |
| Book Value: | 1.76 |
| Earnings Share: | 0.97 |
| EPS Estimate Current Year: | 1.34 |
| EPS Estimate Next Year: | 1.49 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.07 |
| Operating Margin TTM: | 0.15 |
| Return On Assets TTM: | 0.04 |
| Return On Equity TTM: | 0.08 |
| Revenue TTM: | 819697024 |
| Revenue Per Share TTM: | 1.91 |
| Quarterly Revenue Growth YOY: | 0.07 |
| Diluted Eps TTM: | 0.97 |
| Quarterly Earnings Growth YOY: | 0.23 |
Valuation
| Trailing PE: | 30.51 |
| Price Sales TTM: | 15.41 |
| Price Book MRQ: | 2.60 |
| Enterprise Value: | 16356531287 |
| Enterprise Value Revenue: | 2.96 |
| Enterprise Value Ebitda: | 16.04 |
Shares
| Shares Outstanding: | 426934016 |
| Shares Float: | 157807790 |
| Percent Insiders: | 0.10 |
| Percent Institutions: | 80.69 |
Technicals
| Beta: | 0.67 |
| 52 Week High: | 36.3 |
| 52 Week Low: | 26 |
| 50 Day MA: | 29.68 |
| 200 Day MA: | 29.68 |
Splits & Dividends
| Ex Dividend Date: | 2020-03-13 |
Earnings
| Report Date: | 2024-10-22 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Currency: | USD |
| Eps Estimate: | 0.04 |
| Report Date: | 2024-07-23 |
| Date: | 2024-06-30 |
| Before After Market: | Before Market |
| Currency: | USD |
| Eps Actual: | 0.05 |
| Eps Estimate: | 0.05 |
| Report Date: | 2024-04-23 |
| Date: | 2024-03-31 |
| Before After Market: | Before Market |
| Currency: | USD |
| Eps Actual: | 0.02 |
| Eps Estimate: | 0.02 |
| Report Date: | 2023-12-31 |
| Date: | 2023-12-31 |
| Currency: | USD |
| Eps Actual: | 0.32 |
| Eps Estimate: | 0.32 |
| Report Date: | 2023-09-30 |
| Date: | 2023-09-30 |
| Currency: | USD |
| Eps Actual: | 0.03 |
| Eps Estimate: | 0.02 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 5 |
| Date: | 2025-12-31 |
| Period: | +1y |
| Growth: | 0.11 |
| Earnings Estimate Avg: | 1.49 |
| Earnings Estimate Low: | 1.37 |
| Earnings Estimate High: | 1.71 |
| Earnings Estimate Year Ago Eps: | 1.34 |
| Earnings Estimate Number Of Analysts: | 4.00 |
| Earnings Estimate Growth: | 0.11 |
| Revenue Estimate Avg: | 6459160000.00 |
| Revenue Estimate Low: | 6371800000.00 |
| Revenue Estimate High: | 6522530000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.08 |
| Eps Trend Current: | 1.49 |
| Eps Trend7days Ago: | 1.47 |
| Eps Trend30days Ago: | 0.21 |
| Eps Trend60days Ago: | 1.50 |
| Eps Trend90days Ago: | 1.52 |
| Eps Revisions Up Last7days: | 1.00 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2024-12-31 |
| Growth: | 0.36 |
| Earnings Estimate Avg: | 1.34 |
| Earnings Estimate Low: | 1.10 |
| Earnings Estimate High: | 1.64 |
| Earnings Estimate Year Ago Eps: | 0.98 |
| Earnings Estimate Number Of Analysts: | 4.00 |
| Earnings Estimate Growth: | 0.36 |
| Revenue Estimate Avg: | 5933310000.00 |
| Revenue Estimate Low: | 5919610000.00 |
| Revenue Estimate High: | 5960720000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.07 |
| Eps Trend Current: | 1.34 |
| Eps Trend7days Ago: | 1.32 |
| Eps Trend30days Ago: | 0.19 |
| Eps Trend60days Ago: | 1.30 |
| Eps Trend90days Ago: | 1.31 |
| Eps Revisions Up Last7days: | 1.00 |
| Eps Revisions Up Last30days: | 2.00 |
| Date: | 2024-09-30 |
| Growth: | 8.00 |
| Earnings Estimate Avg: | 0.27 |
| Earnings Estimate Low: | 0.27 |
| Earnings Estimate High: | 0.27 |
| Earnings Estimate Year Ago Eps: | 0.03 |
| Earnings Estimate Number Of Analysts: | 1.00 |
| Earnings Estimate Growth: | 8.00 |
| Revenue Estimate Avg: | 1473050000.00 |
| Revenue Estimate Low: | 1473050000.00 |
| Revenue Estimate High: | 1473050000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend Current: | 0.27 |
| Eps Trend7days Ago: | 0.27 |
| Eps Trend30days Ago: | 0.04 |
| Eps Trend60days Ago: | 0.28 |
| Eps Trend90days Ago: | 0.28 |
| Date: | 2024-09-30 |
| Date: | 2023-12-31 |
| Eps Actual: | 0.3 |